Scott Gavura

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

Kelvin Chan, Helen Guo, Sierra Cheng et al. · Cancer Medicine · 2019 · 91 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

International Variability in the Reimbursement of Cancer Drugs by Publically Funded Drug Programs

Parneet Cheema, Scott Gavura, M. Migus et al. · Current Oncology · 2012 · 88 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +11

Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic

Meghan J. Walker, Jonathan Wang, Joshua Mazuryk et al. · JAMA Network Open · 2022 · 85 citations · Full text

Medicine, Health Systems, Oncology +16

The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study

Hart A Goldhar, Andrew T. Yan, Dennis T. Ko et al. · JNCI Journal of the National Cancer Institute · 2015 · 75 citations · Full text

Medicine, Cardiology, Oncology +17

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Kelvin Chan, Seungree Nam, Bill Evans et al. · BMJ Open · 2020 · 55 citations · Full text

Medicine, Oncology, Pharmaceutical Policy +17